Open in interactive viewer → charts, metric popovers & call review

GMR Solutions Trims the Top Line, Defends the Bottom Line — and Names a New 2027 Headwind

Q3 cash and leverage were the beat; the revenue guide narrowed on weather and fuel, and Medicaid work requirements entered the risk list for the first time.
GMRS · Earnings Call · 2026-11-10

A narrower top line, a defended bottom line

GMR Solutions — the country's largest emergency medical services provider, freshly public and carrying a ~$609 million market cap — delivered a Q3 2026 that was better than its headline. Revenue rose 5.9% to $1.6 billion, adjusted EBITDA grew 4.2% to $357 million at a 22.3% margin, net income jumped to $135.6 million from $74.6 million, and free cash flow climbed to roughly $110 million from about $79 million. Management also introduced adjusted diluted EPS of $0.64, a new disclosure for a company still teaching the Street how to model it. Then came the tell. Guidance was narrowed in one direction and held in the other:

We are narrowing our revenue outlook for the year and now expect 2026 revenue to be in the range of $5.9 billion to $6.05 billion, lowering the top end and bringing the midpoint down to $5.975 billion... We are maintaining our full year outlook for adjusted EBITDA in the range of $1.135 billion to $1.195 billion.

Brian Tierney, Executive Vice President and CFO · 2026-11-10
Cutting the top while holding the bottom is a margin-management claim, and to be fair the mechanics support it: a mix shift toward higher-acuity emergent services lifted net revenue per transport 3.0%, while nonemergent transports fell 1.0% by design. But the reason for the revenue trim is worth staring at. It was not pricing. It was flying conditions and the absence of a FEMA hurricane deployment.

Weather has become a revenue line item

Air demand rose 2.8% while transports were essentially flat, because the cancellation rate ran 100 basis points worse year-over-year — the highest third-quarter rate in recent years. Brian Tierney did not dress it up: “I think you said the words there, El Nino.” — Brian Tierney, Executive Vice President and CFO · 2026-11-10 The El Niño pattern is a genuinely global thread this year — it ranked among the very top market-wide themes over the summer — and for GMRS it lands directly on the P&L through grounded aircraft. The structural answer is fleet: the company is buying Bell aircraft and every twin-engine unit going forward will be an IFR aircraft, able to fly on instruments where visual-flight rules stop. That is a multi-year fix arriving in 2027, not a 2026 one. In the meantime, Nick Loporcaro's fallback is redeploying rotor assets out of bad weather — a real lever, but also an admission that a slice of quarterly revenue now floats with the jet stream. Fuel is the other half. The Iran conflict cost roughly $11 million of higher unit fuel in the quarter — consistent with the "$10 million plus a quarter" flagged on the prior call, so this is a recurring tax, not a surprise. What is new is the breadth: “Initially started with transport-related things like freight and travel. But we've seen it really start to pop it into all of the other lines as well.” — Brian Tierney, Executive Vice President and CFO · 2026-11-10 The company's offset is CPI-linked rate escalators in 2027 contracts, procurement and utilization management. Note what is not in this story: tariffs. Tariff refund has been the single dominant cross-market theme of 2026 — the top global keyword in more than one quarter — and GMRS is essentially absent from it. A domestic 911 and air-medical network has no IEEPA exposure and no refund windfall. That is a defensive virtue, and also an explanation for why this name did not participate in the year's biggest thematic trade.

What management stopped selling

The most interesting shift is rhetorical. Nurse Navigation was the company's number-one thematic keyword last quarter, the growth engine pitched across three channels — existing markets, large municipal bids, and the Rural Health Transformation Fund. This quarter it still opened the prepared remarks (32,000 calls, 30 communities, 19 million covered lives, call volume up 51%), yet it has lost its place atop the narrative; the quarter's language is dominated by cost, estimates and mix. Growth stories that stop leading a call usually mean the numbers have not yet caught up to the pitch. The clearest example is the rural fund. In August, Ted Van Horne framed it as a distinct channel: “The second channel is the Rural Health Transformation Fund and the new bids there as we're proposing that across the U.S.” — Edward Van Horne, President and COO · 2026-08-13 In November, the same program got candor instead of enthusiasm:

I will be candid, this first year rollout, we saw a lot of confusion and a lot of the dollars just ultimately went back to the hospitals... It's a little premature to give you an assessment of what the potential is.

Nicola Loporcaro, Board Chair and CEO · 2026-11-10
Those innovative models remain a rank-and-file theme in the language, but the timeline has quietly slipped from pipeline to policy-watch. Meanwhile the IDR process theme, which burned hot last quarter, is cooling by arithmetic rather than by resolution. The No Surprises Act change in estimate was $18 million in Q3 versus roughly $55 million a year earlier; in Q2 it was $5 million against $79 million. “Second quarter, I think, was about $5 million. Third quarter was in the $18 million range. So it's going to be low.” — Brian Tierney, Executive Vice President and CFO · 2026-11-10 Nick Loporcaro still argues the company is “being thrown into a mix unfairly” — Nicola Loporcaro, Board Chair and CEO · 2026-11-10, but the financial controversy is decaying into a comparability footnote. Into that vacuum steps something genuinely new: “What we're watching right now for '27 is the work requirements for Medicaid.” — Brian Tierney, Executive Vice President and CFO · 2026-11-10 A Medicaid work requirement is a live sector theme across healthcare names right now, and GMRS just attached it to its 2027 revenue-per-transport bridge. Add the reconfirmed $16 million-a-quarter payer mix drag from expiring ACA exchange subsidies, and 2027 has two coverage-driven headwinds stacked on top of fuel.

The balance sheet is the actual bull case

Strip out the noise and the quarter's strongest fact is leverage: net debt finished at 3.4x, down from 4.3x a year ago, with line of sight to roughly 3.0x by the end of 2027. The company put $200 million of cash against its term loan, bringing principal to about $2.7 billion, and repriced the facility 50 basis points wider in its favor — roughly $28 million of annual interest savings. Cash stands at $298 million against an undrawn $701 million ABL. That colors capital allocation. “Delevering, I'll say, is priority one on the list.” — Nicola Loporcaro, Board Chair and CEO · 2026-11-10 M&A multiples are, in the CEO's words, "at times a little prohibitive" — a straight continuation of what he said three months ago: “We had hoped and anticipated post the IPO, we would have some arbitrage opportunities. Admittedly, with where we're trading and where the market is evaluating things, I think that's created a bit of conservatism around the pipeline.” — Nicola Loporcaro, Board Chair and CEO · 2026-08-13 Two quarters, same conclusion. The IPO-arbitrage acquisition thesis is shelved; cash goes to debt and aircraft. The tape agrees with that ordering. The stock is up 14.1% over the thirty days into the print but sits 12.2% below its November 5 high of $12.51 — a small-cap post-IPO name that rallied on cash flow and gave some back ahead of a guide that narrowed. There is also a human fact the call opened with and no analyst returned to: a rotor accident off Catalina Island on September 30 killed two team members and a patient, with the FAA and NTSB investigating. In an air-medical model, that is the risk that sits outside every model.

Watch next

Q4 is seasonally the weakest mix quarter, and the company said so. The questions for 2027 guidance are narrow: whether weather normalizes, whether fuel futures behave, whether the Medicaid work requirement gets quantified, and whether Nurse Navigation ever shows up as a reported number rather than a narrative. Until then, GMRS is a deleveraging story wearing an EMS uniform — and the market, so far, is paying for the deleveraging.